GLP-1 sales forecast increased to $150B at TD Cowen
Source: SeekingAlpha
2026-06-05 10:22:45 ET
More on Eli Lilly, Novo Nordisk A/S
- Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
- Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win
- Wall Street Underestimates Novo Nordisk's GLP-1 Comeback
- Lilly halving planned €2.3B investment in Germany: CEO
- Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Read the full article on Seeking Alpha
For further details see:
GLP-1 sales forecast increased to $150B at TD Cowen
Eli Lilly and Company
NASDAQ: LLY
LLY Trading
1.0% G/L:
$1147.79 Last:
2,429,032 Volume:
$1143.38 Open:
LLY Latest News
June 04, 2026 09:47:47 am
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
LLY Stock Data
$977,526,804,738
935,929,919
9.81%
2658
N/A
Pharmaceuticals
Healthcare
US
Indianapolis
